PeerAtlas ICO review, all information about token sale PeerAtlas (ATLAS) | ICORating
  1. Home
  2. ICO
  3. PeerAtlas
PeerAtlas (ATLAS)


Drugs & Healthcare


The mission of PeerAtlas is to spread modern techniques and knowledge in healthcare, free of charge. 


Issuing ATLAS enables a business model that seeks to give PeerAtlas the availability of a free medical resource and the quality of a paid project. ATLAS will transact in two major pathways that directly benefit the project. Firstly, direct donations of ATLAS will be enabled for verified creators of medical articles and algorithms that the community finds useful. This allows contributing professionals to receive compensation for their time and effort. Secondly, medical professionals using the site will be able to send ATLAS tokens to PeerAtlas to process continuing medical education (CME) credits awarded through the PeerAtlas site.


Pre-sale start date 01 May 2018
Pre-sale end date 13 May 2018
Pre-sale token supply 150,000
Token Sale
ICO start date 14 May 2018
ICO end date 14 Jun 2018
ICO token supply 67,000,000
Soft cap 5,000,000 USD (fiat)
Hard cap size 15,000,000 USD (fiat)
Token details
Ticker ATLAS
Type Utility-token
Additional Token Emission No
Accepted Currencies


Bonus Program
  • Pre-ICO - 20%
  • ICO first 25M ATLAS - 20%
  • ICO next 22M ATLAS - 9%
Token distribution
  • 67% - token sale
  • 10% - foundation (frozen 3 months)
  • 10% - foundation (frozen 12 months)
  • 10% - foundation (frozen 24 months)
  • 3% - team (frozen 3 months)


Type of ratings
Hype score

Funding Rounds

Rating Review and Analytics

Investment rating Info NA
Hype score Info Medium
Risk score Info NA
Get Rating
PeerAtlas ICO Contacts
More on ICO


Start ICO 14 May 2018
End ICO 14 Jun 2018
Price 1 ATLAS = 0.25 USD
Product Type Ecosystem
MVP Product design and partially product code
Whitepaper View
PeerAtlas (ATLAS) widget
Rating Get this widget
ICOs that might interest you

Status Pending
Hype score High
Risk score Medium
Basic Review NA

Status Pending
Hype score High
Risk score NA
Basic Review NA

Status Pending
Hype score High
Risk score NA
Basic Review NA

Status Pending
Hype score Medium
Risk score Medium
Basic Review NA